the Effect of Use of Vit d and Probiotic as a Supplementaition in the Treatment of Bronchial Asthma in Patient Aged 6 to 50 Year and Its Effect in Decrasing Excerbation.

NCT06962761 | Completed DMC FDA Drug

• 1 other identifier: MSC\AZ.AST\C11T019\29\227
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

the study of the effect of vit d and probiotic as suprplementaion in the treatment of patient with bonchial asthma and its effect in decreasing number of excerbation

Conditions

Bronchial Asthma

Outcome Measures

Primary Outcomes (1)

• asthma control test

  The ACT has five questions and assesses the frequency of shortness of breath and general asthma symptoms, the use of rescue medications, the effect of asthma on daily functioning, and an overall self-assessment of asthma control in the last four weeks. Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), and high scores reflect greater degrees of asthma control. Asthma is classified as controlled if the score is greater than 19

  3,6 and 12 months

Study Arms (1)

adult and children with bronchial asthma

4 groups 2adult groups 1take the vitd and probiotic andregulartreatment of asthma and another take regulartreatment of asthma only 2 children groups 1take the vitd and probiotic andregulartreatment of asthma and another take regulartreatment of asthma only

Drug: Vit D

Interventions

Vit D DRUG

in this study we use a combination of vit d and probiotics

Also known as: probiotics

adult and children with bronchial asthma

Eligibility Criteria

• Age: 6 Years - 50 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

patient wih bronchial asthma

Sponsors & Collaborators

• Al-Azhar University: lead

Study Sites (1)

ALAzhar university hospital assiut

Asyut, 71717, Egypt

Location

MeSH Terms

Conditions

Asthma

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Intervention Hierarchy (Ancestors)

Dietary Supplements; Food; Diet, Food, and Nutrition; Physiological Phenomena; Food and Beverages

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: resident doctor of chest department Al-Azhar university asyut

Study Record Dates

• First Submitted: April 30, 2025
• First Posted: May 8, 2025
• Study Start: January 2, 2024
• Primary Completion: January 3, 2025
• Study Completion: January 3, 2025
• Last Updated: May 8, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL

Locations

EG (1)